Add like
Add dislike
Add to saved papers

Phasmarhabditis eagyptiaca n. sp. (Nematoda: Rhabditidae) Isolated from Egyptian Terrestrial Snails and Its Role as Control Bio-agent to Gastropods.

Acta Parasitologica 2023 July 20
INTRODUCTION: To date nineteen nematode species in the genus Phasmarhabditis Andrássy, 1976 recorded and described. This paper describes Phasmarhabditis eagyptiaca n. sp. (Nematoda: Rhabditidae), morphologically and phylogenatically and investigate its role as bio control agent for gastropods.

METHODS: Snails infected with nematode collected from Great Cairo Egypt. Sequences of the 18S ribosomal (18S rRNA) gene performed and used for phylogenetic studies. Morphological parameter measured and the nematode photographed and illustrated. Bioassay conducted on some snails and slugs species.

RESULTS: Phasmarhabditis eagyptiaca n. sp. is the second new species of the genus Phasmarhabditis recorded and described in Egypt after Phasmarhabditis tawfiki Azzam2003, the fourth species from Africa and the 20th from the world. Morphological and molecular parameter showed that the new isolate is close to other species of Phasmarhabditis, especially Phasmarhabditis neopapillosa Andrássy, 1983, Phasmarhabditis hermaphrodita (Schneider, 1859) and P. tawfiki Azzam with high bootstrap supported values (99.25%, 98.85%, and 98.64%, respectively). This nematode could infect and killed all snails and slugs exposed to infection in laboratory. Phasmarhabditis eagyptiaca n. sp. differs from all previously recorded species by shorter tail of female spikey tail of male and the arrangement of genital papillae formula which different from all previous species.

CONCLUSION: It could be confirmed that this nematode is a new species of Phasmarhabditis. This nematode could be considering a biological control agent for snails and slugs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app